Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hell

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 1997
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)F X Vollenweider, K L Leenders, I Oye, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000
Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humansM E Liechti, M R Saur, A Gamma, et al.
Neuroreport|January 6, 1999
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist actionF X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 17, 1999
A deviant EEG brain microstate in acute, neuroleptic-naive schizophrenics at restT Koenig, D Lehmann, M C Merlo, et al.
Archives of General Psychiatry|December 15, 2000
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophreniaD Umbricht, L Schmid, R Koller, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000
3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humansA Gamma, A Buck, T Berthold, et al.
Human Brain Mapping|September 18, 2001
Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA)E Frei, A Gamma, R Pascual-Marqui, et al.
Der Nervenarzt|January 13, 2006
[CERAD and NOSGER. Comparing predictive scales for dementia in a Swiss gerontopsychiatric patient population]G Künig, A Kaldune, V Stief, et al.
Neuroreport|February 23, 2000
Mood state and brain electric activity in ecstasy usersA Gamma, E Frei, D Lehmann, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 3, 2004
Nongenetic pathologic developments of brain-wave patterns in monozygotic twins discordant and concordant for schizophreniaM Weisbrod, H Hill, H Sauer, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 1, 1997
Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)F X Vollenweider, K L Leenders, I Oye, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000
Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humansM E Liechti, M R Saur, A Gamma, et al.
Neuroreport|January 6, 1999
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist actionF X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 17, 1999
A deviant EEG brain microstate in acute, neuroleptic-naive schizophrenics at restT Koenig, D Lehmann, M C Merlo, et al.
Archives of General Psychiatry|December 15, 2000
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophreniaD Umbricht, L Schmid, R Koller, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 16, 2000
3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H(2)(15)O]-PET in healthy humansA Gamma, A Buck, T Berthold, et al.
Human Brain Mapping|September 18, 2001
Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA)E Frei, A Gamma, R Pascual-Marqui, et al.
Der Nervenarzt|January 13, 2006
[CERAD and NOSGER. Comparing predictive scales for dementia in a Swiss gerontopsychiatric patient population]G Künig, A Kaldune, V Stief, et al.
Neuroreport|February 23, 2000
Mood state and brain electric activity in ecstasy usersA Gamma, E Frei, D Lehmann, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 3, 2004
Nongenetic pathologic developments of brain-wave patterns in monozygotic twins discordant and concordant for schizophreniaM Weisbrod, H Hill, H Sauer, et al.
Pageof 9